1. Home
  2. SWIN vs FEMY Comparison

SWIN vs FEMY Comparison

Compare SWIN & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWIN
  • FEMY
  • Stock Information
  • Founded
  • SWIN 2017
  • FEMY 2004
  • Country
  • SWIN Hong Kong
  • FEMY United States
  • Employees
  • SWIN N/A
  • FEMY N/A
  • Industry
  • SWIN
  • FEMY Medical/Dental Instruments
  • Sector
  • SWIN
  • FEMY Health Care
  • Exchange
  • SWIN Nasdaq
  • FEMY Nasdaq
  • Market Cap
  • SWIN 32.1M
  • FEMY 28.3M
  • IPO Year
  • SWIN 2023
  • FEMY 2021
  • Fundamental
  • Price
  • SWIN $3.06
  • FEMY $0.98
  • Analyst Decision
  • SWIN
  • FEMY Strong Buy
  • Analyst Count
  • SWIN 0
  • FEMY 3
  • Target Price
  • SWIN N/A
  • FEMY $8.67
  • AVG Volume (30 Days)
  • SWIN 292.8K
  • FEMY 557.5K
  • Earning Date
  • SWIN 08-21-2025
  • FEMY 08-07-2025
  • Dividend Yield
  • SWIN N/A
  • FEMY N/A
  • EPS Growth
  • SWIN N/A
  • FEMY N/A
  • EPS
  • SWIN N/A
  • FEMY N/A
  • Revenue
  • SWIN $2,419,000.00
  • FEMY $1,699,232.00
  • Revenue This Year
  • SWIN N/A
  • FEMY $231.84
  • Revenue Next Year
  • SWIN $61.68
  • FEMY $245.28
  • P/E Ratio
  • SWIN N/A
  • FEMY N/A
  • Revenue Growth
  • SWIN N/A
  • FEMY 61.97
  • 52 Week Low
  • SWIN $1.16
  • FEMY $0.69
  • 52 Week High
  • SWIN $4.17
  • FEMY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • SWIN 79.41
  • FEMY 55.24
  • Support Level
  • SWIN $1.57
  • FEMY $0.85
  • Resistance Level
  • SWIN $3.48
  • FEMY $1.10
  • Average True Range (ATR)
  • SWIN 0.26
  • FEMY 0.08
  • MACD
  • SWIN 0.13
  • FEMY 0.02
  • Stochastic Oscillator
  • SWIN 78.05
  • FEMY 63.50

About SWIN Solowin Holdings

Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: